查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827797

2025年全球口腔給藥系統市場報告

Buccal Drug Delivery System Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，口腔給藥系統市場規模強勁成長，從2024年的35.5億美元成長至2025年的38.9億美元，複合年成長率達9.5%。預測期內的成長可歸因於早期給藥創新、製藥業的應用、臨床研究和療效、市場滲透策略以及針對特定疾病的應用。

預計未來幾年口腔給藥系統市場將快速成長，到2029年將達到58.8億美元，複合年成長率為10.9%。預測期內的成長可歸因於以患者為中心的給藥方式、老年人口的成長、對標靶治療、生技藥品和肽類給藥的需求、監管支持和核准以及研發投入。預測期內的主要趨勢包括患者便利性和依從性、藥物製劑的進步、慢性病的增多、兒科和老年護理的增加以及生物有效性的提高。

頰粘膜給藥系統透過覆蓋口腔的頰粘膜給藥所需藥物。此方法適用於粘膜和粘膜給藥。黏膜給藥旨在在黏膜上進行特異性部位的藥物釋放，而經粘膜滲透是指藥物穿過黏膜屏障吸收進入體循環。

頰部給藥系統的主要類型包括舌下、頰部片劑、含片和口腔噴霧。 「舌下」指頰部藥物全身給藥的給藥途徑。它們在醫院、門診中心和其他醫療機構中用於各種用途，包括疼痛管理、戒菸和心絞痛。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供頰部給藥系統市場統計數據，包括頰部給藥系統行業的全球市場規模、各地區市場佔有率、頰部給藥系統市場佔有率的競爭對手、頰部給藥系統細分市場的詳細情況、市場趨勢和商機，以及您在頰部給藥系統行業取得成功所需的數據。本頰部給藥系統市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供全面的觀點。

未來五年的預測成長率為10.9%，較我們先前對該市場的預測略有下降0.2%。下降的主要原因是美國與其他國家之間的關稅影響。這種影響可能會直接波及美國，導致來自瑞士和印度等主要地區的黏性聚合物薄膜和控制釋放基質材料供應鏈中斷，從而可能減少創新疼痛管理療法的供應，並推高藥品成本。由於互惠關稅以及不斷升級的貿易摩擦和限制對全球經濟和貿易的負面影響，這種影響可能會更加廣泛。

慢性病的日益普及預計將推動未來口腔給藥系統市場的成長。慢性病是指持續時間超過一年的健康問題，例如癌症、心臟病、中風、糖尿病和關節炎。這些疾病可以控制但無法治愈，是最常見的慢性病之一，需要持續的醫療照護和營養支持。口腔給藥系統為黏膜和粘膜給藥提供了一種有效且方便的方法，許多患有糖尿病和癌症等慢性病的患者都需要這種方法。例如，2023 年 9 月，總部位於瑞士的聯合國專門機構世界衛生組織 (WHO) 報告稱，非傳染性疾病 (NCD) 或慢性病每年造成 4,100 萬人死亡，佔全球死亡人數的 74%。其中，心血管疾病導致死亡1,790萬人，癌症導致死亡930萬人，慢性呼吸道疾病導致死亡410萬人，糖尿病導致死亡200萬人。因此，慢性病盛行率的上升正在推動口腔給藥系統市場的成長。

預計醫院需求的不斷成長將推動未來口腔給藥系統市場的成長。醫院是為病人和受傷者提供治療、護理和服務的專門機構。在醫院環境中，口腔給藥系統具有快速藥物吸收、增強病患順從性、減少胃腸道副作用、控制藥物釋放等優勢。例如，2023年5月，代表醫院和醫療保健網路的美國醫療保健產業協會美國醫院協會 (AHA) 報告稱，醫院總數從2022年的6,093家增加到2023年的6,129家。此外，2023年美國所有醫院的住院總人數為34,011,386人次，高於2022年的33,356,853人次。因此，醫院需求的不斷成長正在推動口腔給藥系統市場的成長。

頰部給藥系統市場的主要企業專注於創造創新解決方案，例如斑塊型乾癬的口服治療，以改善患者預後並增強藥物傳遞。斑塊型乾癬的口服治療涉及口服藥物來控制和緩解這種慢性自體免疫疾病的症狀。這種疾病的特徵是皮膚細胞快速增殖，導致出現厚而紅且鱗狀的斑塊。例如，2022 年 9 月，美國製藥公司百時美施貴寶的 Sotyktu (deucravacitinib) 獲得 FDA核准，這是一種用於治療中度至斑塊型乾癬成人的口服治療藥物。這項核准標誌著近十年來該疾病的首個新型口服治療方法，引入了一種新的作用機制—選擇性抑制蛋白酪氨酸激酶2 (TYK2)。

口腔給藥系統市場的公司正專注於新產品的推出以創造收益。例如，2023年2月，Arlak Biotech Private Limited推出了一款褪黑素口腔噴霧。褪黑素口腔噴霧可促進人體自然產生褪黑素，提供一種簡單有效的改善睡眠品質的方法。此類產品類型滿足了特定的醫療保健需求，促進了口腔給藥系統市場的成長。

2023年4月，美國製藥公司DifGen Pharmaceuticals LLC收購了Aveva Drug Delivery Services, Inc.。此次策略性收購增強了DifGen的研發和生產能力，旨在確保可靠地供應高品質、具成本效益的藥品。 Aveva Drug Delivery Services專注於口服給藥系統，這與DifGen提供先進可靠的藥物解決方案的目標一致。

頰部給藥系統市場涵蓋胰島素、尼古丁、替Tizanidine定、曲坦類藥物、硝苯地平、氟比洛芬、羧甲基纖維素鈉、卡波姆、格列本脲、透明質酸和黃原膠等藥物成分的銷售。此市場的價值是指“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值也包括商品製造商提供的相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球頰部給藥系統：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球頰部給藥系統市場：成長率分析
  • 全球口腔給藥系統市場表現：規模與成長，2019-2024
  • 全球口腔給藥系統市場預測：規模與成長，2024-2029，2034
  • 全球頰部給藥系統：總目標市場（TAM）

第6章 市場細分

  • 全球口腔給藥系統市場類型、績效及預測（2019-2024、2024-2029、2034）
  • 舌下片
  • 頰片和錠劑
  • 口腔噴霧劑
  • 全球口腔給藥系統市場應用、績效及預測（2019-2024、2024-2029、2034）
  • 疼痛管理
  • 禁止抽煙
  • 心絞痛
  • 全球口腔給藥系統市場（依最終使用者、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診中心
  • 其他最終用戶
  • 全球頰部給藥系統市場：舌下細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 舌下片
  • 舌下含片
  • 全球口腔給藥系統市場：按類型細分（口腔片劑及含片）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 頰片
  • 口服錠劑
  • 全球頰部給藥系統市場：口腔噴霧劑細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 噴霧溶液
  • 噴霧凝膠

第7章 區域和國家分析

  • 全球口腔給藥系統市場：依地區、績效及預測，2019-2024年、2024-2029年、2034年
  • 全球口腔給藥系統市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 頰部給藥系統市場：競爭格局
  • 頰部給藥系統市場：公司簡介
    • Teva Pharmaceuticals Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
    • Indivior PLC Overview, Products and Services, Strategy and Financial Analysis
    • Generex Biotechnology Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Catalent Inc.
  • Arx Limited Liability Company
  • BioDelivery Science International Incorporated
  • Cynapsus Therapeutics Incorporated
  • Endo Pharmaceuticals Public Limited Company
  • Medlab Clinical Ltd.
  • AstraZeneca PLC
  • F Hoffmann-La Roche Limited
  • Dr. Reddy's Laboratories Ltd.
  • Takeda Pharmaceutical Company Limited
  • Novartis AG
  • Novo Nordisk A/S
  • Ethypharm SAS
  • Applied Pharma Research SA
  • Sunovion Pharmaceuticals Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年口腔給藥系統市場：提供新機會的國家
  • 2029年口腔給藥系統市場：細分領域帶來新機會
  • 2029年口腔給藥系統市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r22440u

The buccal drug delivery system involves administering the desired medicine through the buccal mucosal membrane lining of the mouth cavity. This method is effective for delivering mucosal and transmucosal drugs. Mucosal drug delivery aims for site-specific drug release on the mucosa, whereas transmucosal permeation entails drug absorption across the mucosal barrier and into the systemic circulation.

The main types of buccal drug delivery systems include sublingual, buccal tablets and lozenges, and oral sprays. The term sublingual refers to the route of administration for systemic medication delivery of buccal drugs. These are applied in various applications such as pain management, smoking cessation, and angina pectoris, and are utilized by hospitals, ambulatory care centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The buccal drug delivery system market research report is one of a series of new reports from The Business Research Company that provides buccal drug delivery system market statistics, including buccal drug delivery system industry global market size, regional shares, competitors with a buccal drug delivery system market share, detailed buccal drug delivery system market segments, market trends and opportunities, and any further data you may need to thrive in the buccal drug delivery system industry. This buccal drug delivery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The buccal drug delivery system market size has grown strongly in recent years. It will grow from $3.55 billion in 2024 to $3.89 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to early drug delivery innovations, pharmaceutical industry adoption, clinical studies and efficacy, market penetration strategies, disease-specific applications.

The buccal drug delivery system market size is expected to see rapid growth in the next few years. It will grow to $5.88 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to patient-centric drug delivery, rising geriatric population, demand for targeted therapies, biologics and peptides delivery, regulatory support and approvals, investments in r&d. Major trends in the forecast period include patient convenience and compliance, advancements in drug formulations, rise in chronic diseases, pediatric and geriatric care, enhanced bioavailability.

The forecast of 10.9% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for mucoadhesive polymer films and controlled-release matrix materials, sourced from key regions such as Switzerland and India, which could lead to reduced availability of innovative pain management therapies and increased medication costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases is anticipated to boost the growth of the buccal drug delivery systems market in the future. Chronic diseases are defined as health conditions that last for a year or more, including cancer, heart disease, stroke, diabetes, and arthritis. These illnesses are among the most common chronic conditions that can be managed but not cured, requiring ongoing medical care and nutrition. Buccal drug delivery systems offer an effective and suitable method for administering mucosal and transmucosal drugs needed by many patients suffering from chronic diseases such as diabetes and cancer. For instance, in September 2023, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that 41 million deaths, accounting for 74% of global deaths caused by non-communicable diseases (NCDs) or chronic diseases, occur each year. Among these, there were 17.9 million deaths due to cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the increasing prevalence of chronic diseases is driving the growth of the buccal drug delivery systems market.

The rising demand in hospitals is expected to drive the growth of the buccal drug delivery systems market in the future. Hospitals are specialized facilities that provide medical treatment, care, and services to individuals who are ill or injured. In hospital settings, buccal drug delivery systems offer benefits such as rapid drug absorption, enhanced patient compliance, reduced gastrointestinal side effects, and controlled drug release. For example, in May 2023, a report from the American Hospital Association (AHA), a US-based healthcare trade organization representing hospitals and healthcare networks, indicated that the total number of hospitals increased to 6,129, up from 6,093 in 2022. Additionally, total admissions across all U.S. hospitals rose to 34,011,386, compared to 33,356,853 in 2022. Thus, the increasing demand in hospitals is propelling the growth of the buccal drug delivery systems market.

Leading companies in the buccal drug delivery systems market are concentrating on creating innovative solutions, such as oral treatments for plaque psoriasis, to enhance patient outcomes and improve drug delivery efficacy. Oral treatments for plaque psoriasis involve administering medications by mouth to manage and relieve the symptoms of this chronic autoimmune disorder, which is characterized by the rapid proliferation of skin cells resulting in thick, red, scaly patches. For example, in September 2022, Bristol Myers Squibb, a US-based pharmaceutical company, received FDA approval for Sotyktu (deucravacitinib), an oral treatment for adults suffering from moderate-to-severe plaque psoriasis. This approval represents the first new oral therapy for this condition in nearly a decade, introducing a novel mechanism of action as a selective inhibitor of tyrosine kinase 2 (TYK2).

Companies operating in the buccal drug delivery systems market are focusing on product launches to drive revenues. For instance, in February 2023, launch of melatonin oral spray by Arlak Biotech Private Limited. Melatonin oral spray provides an easy and effective way to facilitate the body's natural production of melatonin, aiding in improving sleep quality. This type of product launch addresses specific healthcare needs, contributing to the growth of the buccal drug delivery systems market.

In April 2023, DifGen Pharmaceuticals LLC, a US-based pharmaceutical company, acquired Aveva Drug Delivery Services Inc. This strategic acquisition aimed to enhance DifGen's research and development (R&D) and manufacturing capabilities, ensuring a secure supply of high-quality and cost-effective medications. Aveva Drug Delivery Services Inc. specializes in buccal drug delivery systems, aligning with DifGen's goal of providing advanced and reliable pharmaceutical solutions.

Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc., Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd., AstraZeneca PLC, F Hoffmann-La Roche Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, Novo Nordisk A/S, Ethypharm SAS, Applied Pharma Research SA, Sunovion Pharmaceuticals Inc., Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc., NAPP Pharmaceutical Ltd., Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc., Par Pharmaceutical Companies Inc., Acorda Therapeutics Inc., Opiant Pharmaceuticals Inc.

North America was the largest region in the buccal drug delivery systems market share in 2024. The regions covered in the buccal drug delivery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the buccal drug delivery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The buccal drug delivery system market consists of the sales of drug ingredients such as insulin, nicotine, tizanidine, triptan, nifedipine, flurbiprofen, sodium carboxymethylcellulose, carbopol, glibenclamide, hyaluronic acid, and xanthan gum. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Buccal Drug Delivery System Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on buccal drug delivery system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for buccal drug delivery system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The buccal drug delivery system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Sublingual; Buccal Tablets And Lozenges; Oral Sprays
  • 2) By Application: Pain Management; Smoking Cessation; Angina Pectoris
  • 3) By End-User: Hospitals; Ambulatory Centers; Other End-Users
  • Subsegments:
  • 1) By Sublingual: Sublingual Tablets; Sublingual Films
  • 2) By Buccal Tablets And Lozenges: Buccal Tablets; Buccal Lozenges
  • 3) By Oral Sprays: Spray Solutions; Spray Gels
  • Companies Mentioned: Teva Pharmaceuticals Industries Ltd.; Pfizer Incorporated; GlaxoSmithKline Public Limited Company; Indivior PLC; Generex Biotechnology Corporation; Catalent Inc.; Arx Limited Liability Company; BioDelivery Science International Incorporated; Cynapsus Therapeutics Incorporated; Endo Pharmaceuticals Public Limited Company; Medlab Clinical Ltd.; AstraZeneca PLC; F Hoffmann-La Roche Limited; Dr. Reddy's Laboratories Ltd.; Takeda Pharmaceutical Company Limited; Novartis AG; Novo Nordisk A/S; Ethypharm SAS; Applied Pharma Research SA; Sunovion Pharmaceuticals Inc.; Sanofi SA; Bayer AG; Adare Pharmaceuticals Inc.; NAPP Pharmaceutical Ltd.; Perrigo Company PLC; Reckitt Benckiser Group PLC; Teligent Pharma Inc.; Par Pharmaceutical Companies Inc.; Acorda Therapeutics Inc.; Opiant Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Buccal Drug Delivery System Market Characteristics

3. Buccal Drug Delivery System Market Trends And Strategies

4. Buccal Drug Delivery System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Buccal Drug Delivery System Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Buccal Drug Delivery System PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Buccal Drug Delivery System Market Growth Rate Analysis
  • 5.4. Global Buccal Drug Delivery System Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Buccal Drug Delivery System Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Buccal Drug Delivery System Total Addressable Market (TAM)

6. Buccal Drug Delivery System Market Segmentation

  • 6.1. Global Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sublingual
  • Buccal Tablets And Lozenges
  • Oral Sprays
  • 6.2. Global Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Management
  • Smoking Cessation
  • Angina Pectoris
  • 6.3. Global Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Centers
  • Other End-Users
  • 6.4. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Sublingual, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sublingual Tablets
  • Sublingual Films
  • 6.5. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Buccal Tablets And Lozenges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Buccal Tablets
  • Buccal Lozenges
  • 6.6. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Oral Sprays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spray Solutions
  • Spray Gels

7. Buccal Drug Delivery System Market Regional And Country Analysis

  • 7.1. Global Buccal Drug Delivery System Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Buccal Drug Delivery System Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Buccal Drug Delivery System Market

  • 8.1. Asia-Pacific Buccal Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Buccal Drug Delivery System Market

  • 9.1. China Buccal Drug Delivery System Market Overview
  • 9.2. China Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Buccal Drug Delivery System Market

  • 10.1. India Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Buccal Drug Delivery System Market

  • 11.1. Japan Buccal Drug Delivery System Market Overview
  • 11.2. Japan Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Buccal Drug Delivery System Market

  • 12.1. Australia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Buccal Drug Delivery System Market

  • 13.1. Indonesia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Buccal Drug Delivery System Market

  • 14.1. South Korea Buccal Drug Delivery System Market Overview
  • 14.2. South Korea Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Buccal Drug Delivery System Market

  • 15.1. Western Europe Buccal Drug Delivery System Market Overview
  • 15.2. Western Europe Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Buccal Drug Delivery System Market

  • 16.1. UK Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Buccal Drug Delivery System Market

  • 17.1. Germany Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Buccal Drug Delivery System Market

  • 18.1. France Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Buccal Drug Delivery System Market

  • 19.1. Italy Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Buccal Drug Delivery System Market

  • 20.1. Spain Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Buccal Drug Delivery System Market

  • 21.1. Eastern Europe Buccal Drug Delivery System Market Overview
  • 21.2. Eastern Europe Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Buccal Drug Delivery System Market

  • 22.1. Russia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Buccal Drug Delivery System Market

  • 23.1. North America Buccal Drug Delivery System Market Overview
  • 23.2. North America Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Buccal Drug Delivery System Market

  • 24.1. USA Buccal Drug Delivery System Market Overview
  • 24.2. USA Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Buccal Drug Delivery System Market

  • 25.1. Canada Buccal Drug Delivery System Market Overview
  • 25.2. Canada Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Buccal Drug Delivery System Market

  • 26.1. South America Buccal Drug Delivery System Market Overview
  • 26.2. South America Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Buccal Drug Delivery System Market

  • 27.1. Brazil Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Buccal Drug Delivery System Market

  • 28.1. Middle East Buccal Drug Delivery System Market Overview
  • 28.2. Middle East Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Buccal Drug Delivery System Market

  • 29.1. Africa Buccal Drug Delivery System Market Overview
  • 29.2. Africa Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Buccal Drug Delivery System Market Competitive Landscape And Company Profiles

  • 30.1. Buccal Drug Delivery System Market Competitive Landscape
  • 30.2. Buccal Drug Delivery System Market Company Profiles
    • 30.2.1. Teva Pharmaceuticals Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. GlaxoSmithKline Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Indivior PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Generex Biotechnology Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Buccal Drug Delivery System Market Other Major And Innovative Companies

  • 31.1. Catalent Inc.
  • 31.2. Arx Limited Liability Company
  • 31.3. BioDelivery Science International Incorporated
  • 31.4. Cynapsus Therapeutics Incorporated
  • 31.5. Endo Pharmaceuticals Public Limited Company
  • 31.6. Medlab Clinical Ltd.
  • 31.7. AstraZeneca PLC
  • 31.8. F Hoffmann-La Roche Limited
  • 31.9. Dr. Reddy's Laboratories Ltd.
  • 31.10. Takeda Pharmaceutical Company Limited
  • 31.11. Novartis AG
  • 31.12. Novo Nordisk A/S
  • 31.13. Ethypharm SAS
  • 31.14. Applied Pharma Research SA
  • 31.15. Sunovion Pharmaceuticals Inc.

32. Global Buccal Drug Delivery System Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Buccal Drug Delivery System Market

34. Recent Developments In The Buccal Drug Delivery System Market

35. Buccal Drug Delivery System Market High Potential Countries, Segments and Strategies

  • 35.1 Buccal Drug Delivery System Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Buccal Drug Delivery System Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Buccal Drug Delivery System Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer